Invited Commentary

Commentary on “Lessons Learned from Building a Pediatric-to-Adult Sickle Cell Transition Program”

Authors: Sara Mixter, MD, MPH, Rosalyn W. Stewart, MD, MS, MBA
diagnostic:291440

Abstract

In their article “Lessons Learned from Building a Pediatric-to-Adult Sickle Cell Transition Program,” which appears in this issue of the Southern Medical Journal, Smith and colleagues highlight the challenges of the healthcare transition for this already high-risk population.1 The problem cannot be understated.
Posted in: Hematology6

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Smith WR, Sisler IY, Johnson S, et al. Lessons learned from building a pediatric-to-adult sickle cell transition program. South Med J 2019;112:190-197.
2. Quinn CT, Rogers ZR, McCavit TL, et al. Improved survival of children and adolescents with sickle cell disease. Blood 2010;115:3447-3452.
3. McLaughlin JF, Ballas SK. High mortality among children with sickle cell anemia and overt stroke who discontinue blood transfusion after transition to an adult program. Transfusion 2016;56:1014-1021.
4. White PW, Cooley WC, , Transitions Clinical Report Authoring Group, et al. Supporting the health care transition from adolescence to adulthood in the medical home. Pediatrics 2018;142:e20182587.